Indian Council of Medical Research, New Delhi, India.
Indian J Med Microbiol. 2023 Sep-Oct;45:100366. doi: 10.1016/j.ijmmb.2023.100366. Epub 2023 Apr 3.
The COVID-19 pandemic exerted manifold pressures on the public health framework globally, but it also in a way unified different genres and allowed for strategizing and implementing regulatory decisions as best as possible, especially in India. There is an unmet need for such a unified and integrative approach in the area of scientific publishing which has also been touched by various dilemmas, either emergent or propagated during this pandemic.
This article intends to re-visit some of the dilemmas in scientific publishing, which have taken centre stage owing to a healthcare emergency, with the objective of highlighting an unmet need for developing unified criteria for research conduction and publishing from a futuristic view point, as one is not without the other.
While a fast track delivery of research data has been a priority for research journals, the due pressures in the process management of the same while skimming the ethical boundaries of responsible mediation through a Journal platform has remained a challenge globally for various reasons. Furthermore, the inevitability of a healthcare emergency inadvertently led to some cumulative off-target effects including accumulation of research waste, diminishing validity of academic metrics, short data set publications, hasty zombie clinical trials publishing merely an overview of the actual data, etc, which are major issues not only for journal Editors or the research community as a whole, but also for regulatory authorities and policy makers. As a step towards future pandemic preparedness, strategizing and streamlining research and publication processes ensuing responsible reporting should be treated as a topic of paramount significance. Hence, through debating on these dilemmas as well as potential integrative approaches, unified guiding criteria in the area of scientific publishing may be developed in lieu of preparedness for such future pandemic scenarios.
新冠疫情在全球范围内对公共卫生体系造成了多方面的压力，但它也在一定程度上统一了不同类型的工作，并尽可能地制定和实施监管决策，尤其是在印度。在科学出版领域，人们也需要这种统一和综合的方法，该领域也受到了各种困境的影响，无论是在疫情期间出现的还是传播的。
本文旨在重新审视科学出版领域的一些困境，这些困境由于医疗保健紧急情况而成为焦点，目的是强调从未来的角度制定统一的研究开展和出版标准的未满足需求，因为两者缺一不可。
虽然快速发布研究数据一直是研究期刊的优先事项，但由于各种原因，在处理研究数据的过程中，同时在期刊平台上对负责任的调解进行监管的边界进行微调，这在全球范围内仍然是一个挑战。此外，医疗保健紧急情况的必然性不可避免地导致了一些累积的非目标影响，包括研究浪费的积累、学术指标有效性的降低、数据集较短的出版物、仓促发布的僵尸临床试验，仅概述了实际数据等，这些问题不仅对期刊编辑或整个研究界，而且对监管机构和决策者都是主要问题。作为为未来大流行做准备的一步，应将规划和简化研究和出版流程并进行负责任的报告视为至关重要的主题。因此，通过对这些困境以及潜在的综合方法进行辩论，可以制定科学出版领域的统一指导标准，以应对未来的大流行情景。
